Brecht Attema

Brecht Attema is a Researcher at the University Medical Center Groningen (UMCG), Faculty of Medical Sciences, actively contributing to the Metabolism and Transport (MT) and Senescence, Stem Cells, and Inflammation (SSI) research groups. His institutional affiliation places him within the University of Groningen's medical research ecosystem, focusing on translational gastrointestinal science.

Dr. Attema's research centers on the critical intersection of gut microbiome dynamics and mucosal healing, with particular emphasis on how microbiome-derived secondary bile acids facilitate repair of injured colonic tissue. His work investigates the mechanistic links between bacterial metabolites (especially bile acids), inflammatory bowel disease (IBD) pathophysiology, and tissue regeneration processes. This research has direct implications for developing novel microbiome-targeted therapies for conditions like ulcerative colitis and Crohn's disease, leveraging insights from metabolite profiling and host-microbe interactions.

His recent May 2025 publication in EMBO Molecular Medicine demonstrates active contribution to the field, revealing how specific bacterial metabolites promote mucosal healing. The study has garnered scholarly attention with 3 Mendeley readers and cross-platform references, indicating relevance to the wider research community. While specific grant details aren't public, the publication's timeliness suggests ongoing funded research within UMCG's collaborative infrastructure.

Dr. Attema collaborates with established researchers like F. Kuipers and operates within UMCG's dual research group structure. Prospective students would engage with advanced methodologies in microbiome analysis, metabolomics, and colonic injury models, contributing to projects aimed at translating basic discoveries into clinical applications for inflammatory bowel diseases.